Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveC-reactive protein: a critical updateElevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genesMAPK-dependent regulation of IL-1- and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress responseFluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination SurveyPotential role of ultrafine particles in associations between airborne particle mass and cardiovascular health.From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for AtheroprotectionInflammation, plaque progression and vulnerability: evidence from intravascular ultrasound imagingRelations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factorsOpportunities for the treatment of inflammation in cardiovascular diseaseSerial changes in plasma levels of cytokines in patients with coronary artery diseaseCritical appraisal of C-reactive protein throughout the spectrum of cardiovascular diseaseFenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewPrognostic Impact of 9-Month High-Sensitivity C-Reactive Protein Levels on Long-Term Clinical Outcomes and In-Stent Restenosis in Patients at 9 Months after Drug-Eluting Stent ImplantationObstructive Sleep Apnea Is Associated with Elevated High Sensitivity C-Reactive Protein Levels Independent of Obesity: Korean Genome and Epidemiology StudyCirculating fibrocytes as predictors of adverse events in unstable anginaDetection of the inflammation biomarker C-reactive protein in serum samples: towards an optimal biosensor formula.Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.The challenges for molecular nutrition research 2: quantification of the nutritional phenotype.A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing.C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study.Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosaProtective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.Cardiovascular disease could be contained based on currently available data!Effects of C-reactive Protein and Homocysteine on Cytokine Production: Modulation by Pravastatin.Inflammation, the acute phase response and atherosclerosis.Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort studyInflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early lifeAssociations of brain-natriuretic peptide, high-sensitive troponin T, and high-sensitive C-reactive protein with outcomes in severe aortic stenosis.Low grade inflammation and coronary heart disease: prospective study and updated meta-analysesChlamydia pneumoniae and other risk factors for atherosclerosis.Systemic inflammation in cardiovascular and periodontal disease: comparative studyRole of infectious and immune factors in coronary and cerebrovascular arteriosclerosisThe levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people.Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria.Pentraxin 3 as a novel marker predicting congestive heart failure in subjects with acute coronary syndromeAtherosclerosis and autoimmunity.Mitral valve restenosis after percutaneous transmitral valvuloplasty, role of continuous inflammationUsefulness of C-reactive protein as a marker for prediction of future coronary events in the asian Indian population: Indian atherosclerosis research study.
P2860
Q24594814-641FA3E4-82E0-4033-A48D-7F3F577589E0Q24672855-3F4F27DC-EDC5-4DC0-942B-5CC38E0976A6Q24793954-FB4A95B3-37C9-4449-962D-6388D5700CFAQ24798967-A2CE87F1-C171-4CE7-81A6-B430B2E56CDBQ24806340-A61B94E0-C1AA-451F-8869-61735171BE6FQ24813777-016B41CF-D252-4647-940F-704B9EF23C01Q24815147-CF7B541D-BE03-4BB2-8A42-22DA3D95AEA0Q26770209-812E13D2-AF1C-4825-9EAD-A3D690B85C92Q26786663-F6B7094A-3FE0-4B31-8B8F-1F3C9A0E91B2Q28177167-AE63898F-EBC5-4300-96A8-768C7016B3E4Q28192292-50D5C432-4AD4-4F5F-8BA2-6991EF311912Q28219344-81CC8023-634E-48C1-8F5F-5D828DAA819FQ28219483-DD8BE3C9-DC3E-41DA-A3B0-EC4CDBA1AD5EQ28220294-C7E99E99-8721-490D-A2A8-35CD02A8136CQ28548500-F3B9F69D-BD89-4E65-B2CF-D163150AEE17Q28554387-9810E7C2-354B-454A-BDB5-9F3A9B6F0F7AQ30277093-419729C1-0587-41C8-9AB3-8A0755D8C912Q30420948-E23819A7-D740-4A74-AF4B-21F9AA139E4CQ30475959-8B340EF7-BDD6-47C4-BC10-4C1666CA8F1BQ30493853-13A118FD-7F86-4FAB-8AA3-BCFA11EFB36BQ30494320-009E4FC1-B013-4C3D-86BE-A16F75A39530Q30763122-26021D9E-BF32-4D16-B066-855EA43E0A2EQ30881300-E020D2F2-BD47-40BE-8DC4-329EBFEFF565Q31005025-13474D2B-9878-49D0-9622-AE2F0454F312Q31164692-9325BF81-53AF-4686-A5AF-6E31885B3457Q33633640-367FDD95-FA5D-46E0-BD3B-CA7C13F37783Q33694694-2E00B053-D1B8-440F-9333-A3E580DC84C4Q33699467-8063C67E-EAB5-4D06-B174-D63D5C123A67Q33735189-4BA82B3C-713F-4C04-B068-AAB5FA35BBFBQ33788258-BE84CA8C-6041-4460-8112-729F52AF9900Q33910496-1FADD3B0-1DBD-4556-A8B9-007E1B8B0B6DQ33935014-2ABD1EAD-E1F5-4DDE-A4F9-FAE7C3C94475Q33941972-3262B6D6-834E-46FC-87DA-D1531495DE92Q33942966-40B62860-1067-4ABB-AA6E-CD6821BFFC83Q34020389-6C467992-F18D-4D73-A1F8-2D9376B8B85FQ34077617-FE25D44D-922C-46F1-A7B3-126334479A74Q34104578-A0D2B1C7-0874-42AE-9A0E-E38ED57CBD94Q34243799-82375320-ADD0-4A27-AED9-9D9B9B0A9565Q34333491-4C3DE4A8-72C3-4A62-B92B-761A01D03CE5Q34341013-09259529-6DDF-4C29-9AB3-7417BF236160
P2860
Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Production of C-reactive prote ...... s Angina Pectoris Study Group.
@ast
Production of C-reactive prote ...... s Angina Pectoris Study Group.
@en
Production of C-reactive prote ...... s Angina Pectoris Study Group.
@nl
type
label
Production of C-reactive prote ...... s Angina Pectoris Study Group.
@ast
Production of C-reactive prote ...... s Angina Pectoris Study Group.
@en
Production of C-reactive prote ...... s Angina Pectoris Study Group.
@nl
prefLabel
Production of C-reactive prote ...... s Angina Pectoris Study Group.
@ast
Production of C-reactive prote ...... s Angina Pectoris Study Group.
@en
Production of C-reactive prote ...... s Angina Pectoris Study Group.
@nl
P2093
P1433
P1476
Production of C-reactive prote ...... s Angina Pectoris Study Group.
@en
P2093
F Haverkate
J R Gallimore
S G Thompson
P304
P356
10.1016/S0140-6736(96)07591-5
P407
P50
P577
1997-02-01T00:00:00Z